{
    "organizations": [],
    "uuid": "9494ebdb0efefda11024dcf943c83f4e6c4b0de4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-n4-pharma-names-andrew-leishman-as/brief-n4-pharma-names-andrew-leishman-as-head-of-nuvec-development-idUSFWN1QQ02N",
    "ord_in_thread": 0,
    "title": "BRIEF-N4 Pharma Names Andrew Leishman As Head Of Nuvec Development",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - N4 Pharma Plc:\n* SAYS ANNOUNCES APPOINTMENT OF ANDREW LEISHMAN AS HEAD OF NUVEC DEVELOPMENT\n* SAYS COMPANY IS PROACTIVELY LOOKING TO WORK WITH PARTNERS TO EVALUATE ITS NUVEC SYSTEM WITH THEIR PRODUCTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T15:26:00.000+02:00",
    "crawled": "2018-03-09T14:23:01.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "n4",
        "pharma",
        "plc",
        "say",
        "announces",
        "appointment",
        "andrew",
        "leishman",
        "head",
        "nuvec",
        "development",
        "say",
        "company",
        "proactively",
        "looking",
        "work",
        "partner",
        "evaluate",
        "nuvec",
        "system",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}